(2022) Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit. Case reports in medicine. p. 9880827. ISSN 1687-9627 (Print) 1687-9635 (Electronic)
Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/35991338
Abstract
Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.
| Item Type: | Article |
|---|---|
| Page Range: | p. 9880827 |
| Journal or Publication Title: | Case reports in medicine |
| Journal Index: | Pubmed |
| Volume: | 2022 |
| Identification Number: | https://doi.org/10.1155/2022/9880827 |
| ISSN: | 1687-9627 (Print) 1687-9635 (Electronic) |
| Depositing User: | خانم ناهید ضیائی |
| URI: | http://eprints.mui.ac.ir/id/eprint/24166 |
Actions (login required)
 |
View Item |